Studio clinico NCT07361562 · Non-Small Cell Lung Cancer

Studio clinico NCT07361562 (fase I) risulta «in reclutamento» su ClinicalTrials.gov.

Patologia: Non-Small Cell Lung Cancer · Interventi registrati: CGT4255 · Date registrate (fonte): 2025-12-30, 2028-05, 2026-01-23, 2026-09-04.

Sintesi dello studio (fonte: ClinicalTrials.gov, testo originale in inglese):

This is an open-label, phase 1/1b study evaluating the safety, tolerability, pharmacokinetic (what the body does to the drug), pharmacodynamic (what the drug does to the body), and antitumor activity of CGT4255 in adult participants with advanced solid tumors with ERBB2 alterations or HER2 overexpression.

Fonte: https://clinicaltrials.gov/study/NCT07361562